Insider Trading: Alkermes Plc (ALKS.O)

ALKS.O on Nasdaq

28.91USD
19 Jun 2013
Price Change (% chg)

$-1.00 (-3.34%)
Prev Close
$29.91
Open
$29.82
Day's High
$30.04
Day's Low
$28.80
Volume
814,139
Avg. Vol
1,441,281
52-wk High
$34.30
52-wk Low
$15.69

Search Stocks
MITCHELL PAUL J
Trading Date Type Shares Traded Price Shares Held
1 Apr 2013 Sell 10,000 $23.09 8,000
1 Apr 2013 Buy 10,000 $13.44 8,000
27 Mar 2013 Sell 10,000 $24.00 8,000
27 Mar 2013 Buy 10,000 $13.44 8,000
6 Jan 2013 Sell 19,000 $21.00 8,000
6 Jan 2013 Buy 11,000 $9.91 8,000
6 Jan 2013 Buy 8,000 $9.91 8,000
24 Sep 2012 Sell 9,000 $21.00 8,000
24 Sep 2012 Buy 9,000 $9.91 8,000

Institutional Holders

% Shares Owned: 95.62%
# of Holders: 250
Total Shares Held: 129,275,326
3 Mo. Net Change: 7,370,866
# New Positions: 40
# Closed Positions: 25
# Increased Positions: 130
# Reduced Positions: 90
# Net Buyers: 40

Officers & Directors

Name Age Since Current Position

Richard Pops

50 2011 Chairman of the Board, Chief Executive Officer

Shane Cooke

50 2011 President

James Frates

45 2011 Chief Financial Officer, Senior Vice President

Gordon Pugh

54 2011 Chief Operating Officer, Senior Vice President, Chief Risk Officer

Kathryn Biberstein

53 2011 Senior Vice President, Chief Compliance Officer, General Counsel, Secretary

James Botkin

63 2011 Senior Vice President - Operations

Elliot Ehrich

53 2011 Senior Vice President - Research and Development, Chief Medical Officer

Michael Landine

58 2011 Senior Vice President - Corporate Development

Mark Stejbach

49 2012 Senior Vice President, Chief Commercial Officer

Mark Skaletsky

2011 Lead Independent Director

Nancy Wysenski

2013 Director

David Anstice

64 2011 Independent Director

Floyd Bloom

75 2011 Independent Director

Robert Breyer

68 2011 Independent Director

Wendy Dixon

56 2011 Independent Director

Geraldine Henwood

59 2011 Independent Director

Paul Mitchell

59 2011 Independent Director
Search Stocks